Macrogenics Inc Live Share Price Today, Share Analysis and Chart
about
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast...
Read More46,442 XNAS Volume
XNAS 07 May, 2025 10:08 AM (EDT)
Board Meeting
The next board meeting for Macrogenics Inc is on 09 May 2025 for the purpose of Macrogenics Inc First Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Macrogenics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..